Literature DB >> 24461296

In vitro phenotypic screening of 7-chloro-4-amino(oxy)quinoline derivatives as putative anti-Trypanosoma cruzi agents.

Cristina Fonseca-Berzal1, Fernando A Rojas Ruiz2, José A Escario3, Vladimir V Kouznetsov2, Alicia Gómez-Barrio3.   

Abstract

In this study, a series of 22 pre-synthesized 7-chloro-4-amino(oxy)quinoline derivatives was assayed in vitro as potential antichagasic agents. A primary screening against Trypanosoma cruzi epimastigotes and a non-specific cytotoxicity assay on murine fibroblasts were simultaneously performed, resulting quinolines 3, 7 and 12 with great selectivity (SI) on the extracellular parasite (SI7, SI3, SI12 and SIBZ >9.44). Therefore, the activity of these derivatives was evaluated on intracellular amastigotes, achieving derivative 7 the best SI (SI=12.73). These results, supported by the in silico prediction of a good oral bioavailability and a suitable risk profile, propose the 4-amino-7-chloroquinoline scaffold as a potential template for designing trypanocidal prototypes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chloroquinoline derivatives; Cytotoxicity; Lipinski’s rule; OSIRIS software; Trypanosoma cruzi

Mesh:

Substances:

Year:  2014        PMID: 24461296     DOI: 10.1016/j.bmcl.2013.12.071

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

Review 1.  Perspectives on medicinal properties of natural phenolic monoterpenoids and their hybrids.

Authors:  Jamatsing D Rajput; Suresh D Bagul; Umesh D Pete; Chetan M Zade; Subhash B Padhye; Ratnamala S Bendre
Journal:  Mol Divers       Date:  2017-10-07       Impact factor: 2.943

2.  Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3-PEX19 Interaction.

Authors:  Mengqiao Li; Stefan Gaussmann; Bettina Tippler; Julia Ott; Grzegorz M Popowicz; Wolfgang Schliebs; Michael Sattler; Ralf Erdmann; Vishal C Kalel
Journal:  Front Cell Dev Biol       Date:  2021-12-20

3.  Screening of chemical compound libraries identified new anti-Toxoplasma gondii agents.

Authors:  Oluyomi Stephen Adeyemi; Tatsuki Sugi; Yongmei Han; Kentaro Kato
Journal:  Parasitol Res       Date:  2017-12-19       Impact factor: 2.289

4.  Comparative sequence- and structure-inspired drug design for PilF protein of Neisseria meningitidis.

Authors:  Abijeet Singh Mehta; Kirti Snigdha; M Sharada Potukuchi; Panagiotis A Tsonis
Journal:  Hum Genomics       Date:  2015-04-19       Impact factor: 4.639

5.  Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.

Authors:  Guilherme Curty Lechuga; Júlio Cesar Borges; Claudia Magalhães Calvet; Humberto Pinheiro de Araújo; Aline Araujo Zuma; Samara Braga do Nascimento; Maria Cristina Machado Motta; Alice Maria Rolim Bernardino; Mirian Claudia de Souza Pereira; Saulo Cabral Bourguignon
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2016-07-14       Impact factor: 4.077

6.  Treatment of Trypanosoma cruzi with 2-bromopalmitate alters morphology, endocytosis, differentiation and infectivity.

Authors:  Cassiano Martin Batista; Rafael Luis Kessler; Iriane Eger; Maurilio José Soares
Journal:  BMC Cell Biol       Date:  2018-08-31       Impact factor: 4.241

7.  An aromatic imidazoline derived from chloroquinoline triggers cell cycle arrest and inhibits with high selectivity the Trypanosoma cruzi mammalian host-cells infection.

Authors:  Roberto I Cuevas-Hernández; Richard M B M Girard; Luka Krstulović; Miroslav Bajić; Ariel Mariano Silber
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29

8.  In Vitro Screening to Identify Anti-Toxoplasma Compounds and In Silico Modeling for Bioactivities and Toxicity.

Authors:  Oluyomi Stephen Adeyemi; Olubunmi Atolani; Oluwakemi Josephine Awakan; Tomilola Debby Olaolu; Charles Obiora Nwonuma; Omokolade Alejolowo; David Adeiza Otohinoyi; Damilare Rotimi; Akinyomade Owolabi; Gaber El-Saber Batiha
Journal:  Yale J Biol Med       Date:  2019-09-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.